tiprankstipranks

Joris Wilms Insider Profile

4 Followers
Joris Wilms, SVP & COO at Y-Mabs Therapeutics, holds 52.10K shares in Y-Mabs Therapeutics (Ticker: YMAB).
tipranks
Joris Wilms

Joris Wilms
Y-Mabs Therapeutics (YMAB)
SVP & COO

Not Ranked
Joris Wilms has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$311K
100.00%
A breakdown of Joris Wilms's holdings

Insider Roles

Y-Mabs Therapeutics
(YMAB)
SVP & COO
Roles that Joris Wilms holds in companies

Most Profitable Insider Trade

Stock:
Y-Mabs Therapeutics
(YMAB)
Rating:Informative Sell
Date:Aug 27, 2024 - Today
Return:+58.80%
The most profitable trade made by Joris Wilms

Joris Wilms's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Y-Mabs Therapeutics
Jan 22, 2025
SVP & COO
Uninformative Buy
$311.04K
Success Rate for
YMAB
1 out of 1 profitable transactions on
YMAB
100%
Average Return for
YMAB
Average return per transaction on
YMAB
+58.80%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jan 19, 2023
Uninformative Buy
$0.00
-
$0.00
Jan 22, 2024
Uninformative Buy
$0.00
-
$0.00
Jan 22, 2025
Uninformative Buy
$0.00
-
$0.00
Aug 27, 2024
Informative Sell
$73.45K
-
$14.69
+58.80%
List of latest transactions for each holding click on a transaction to see Joris Wilms's performance on stock

Joris Wilms insider profile FAQ

What is the percentage of profitable transactions made by Joris Wilms?
The percentage of profitable transactions made by Joris Wilms is ―.
    What is the average return per transaction made by Joris Wilms?
    The average return per transaction made by Joris Wilms is ―.
      What stocks does Joris Wilms hold?
      Joris Wilms holds: YMAB stocks.
        What was Joris Wilms’s latest transaction?
        Joris Wilms latest transaction was an Uninformative Buy of ―.
          What was Joris Wilms's most profitable transaction?
          Joris Wilms’s most profitable transaction was an Informative Sell of YMAB stock on August 27, 2024. The return on the trade was 58.80%.
            What is Joris Wilms's role in Y-Mabs Therapeutics?
            Joris Wilms's role in Y-Mabs Therapeutics is SVP & COO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.